Axtria Blog

Axtria’s benchmark study on analytics innovation readiness @ PMSA 2017!

Following on from our first PMSA blog post on the pre-conference tutorial, we would now like to draw your attention to the thought-leading presentations we have planned on April 25th

Read More

Axtria will begin with pre-conference tutorial at PMSA 2017!

Axtria shares a long association with Pharmaceutical Management Science Association (PMSA), and we are excited to be back at this year’s conference as a Gold Sponsor. Axtria has a lot of activity planned between April 23rd and 26th with thought-leading presentations, informative conference tutorials, engaging poster, innovative showcases and lots of networking opportunities.

Read More

Discover the Magic with Axtria at PMSA 2017!

There is no doubt that the Pharmaceutical Management Science Association’s (PMSA) annual conference is one of the most eagerly awaited events on the Pharma calendar. This year’s theme is “Discover the Magic” with a focus on the leading trends in Pharma analytics.

Read More

Deep Dive Into Real World Data

We are excited to announce that Axtria’s Randy Risser and Sudeep Saha will be running a deep-dive workshop on Real World Data at PMSA’s 2017 Winter Symposium. The event takes place from January 12-13 at the Hilton Gaslamp Quarter, San Diego, California. Axtria's workshop starts at 9:45am on Friday. 

Read More

PMSA Presentation on “Application of diagnostic test data in Oncology”

Targeted therapies have generated great interest amongst pharmaceutical manufacturers and several products are currently being commercialized. With the advent of advanced data sources provided by companies who perform these diagnostic tests, it becomes more critical pharmaceutical manufacturers to enhance their understanding of diagnosis, testing, and treatment behaviors while building capabilities around the targeted therapies with accurate forecasting. The diagnostic testing data provided by the laboratories helps in evaluating the overall genetic testing landscape ranging from academic to commercial laboratories and make commercial recommendations around forecasting and localized decision making.

Read More

Analytics-Enabled Sales Alignment Process Streamlines Sales Crediting and Eligibility

Sales crediting and eligibility are two of the most common challenges that organizations face in managing their Incentive Compensation programs. Traditionally, these processes have relied on accurate alignment and roster data to determine the right individual to get sales credit, the absence of which causes IC & other downstream systems to wonder ‘what happened’ well after ‘it happened’.

Read More

People Placement problems in Life Sciences Sales: Challenges and Opportunities

People Placement constitutes the activities related to assignment of sales reps, following any major sales force territory alignment or change in the size and structure of sales force. Placing the best available rep into each territory is critical to the success of any sales force realignment effort.

Read More

Calling all wannabe gamblers!!

We are delighted to announce our participation as a Gold Sponsor in the upcoming PMSA Annual conference, to be held on 17th to 20th April 2016 at Planet Hollywood Las Vegas. We are looking forward to meeting with senior pharma business leadership and discussing the role of management and decision science in the continually evolving commercial landscape. 

Read More

Axtria delivered its fourth session on ‘Targeting & Call Planning’ during PMSA Webinar Series 2015 on 28th October

In continuation with the three earlier PMSA Webinars delivered on Commercial Operations, Axtria delivered its fourth insightful webinar on Targeting & Call Planning, which shed light on the detailed tactical steps undertaken as a part of sales and marketing execution. The session conducted by Axtria experts Chet Baboor and Vineet Rathi covered typical approaches and techniques, key decisions involved and typical benefits of Call Planning exercise in an environment increasingly impacted by parameters like shrinking sales forces, reduced physician access, influence migrating from physician to system/payer contracts, etc.

Read More